TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists ... target peak concentrations or a rapid onset of action. Studies in patients with type 2 diabetes ...